Kalmuss D, Davidson A, Cushman L, Heartwell S, Rulin M
Center for Population and Family Health, Columbia University, New York, NY 10032, USA.
Am J Public Health. 1998 Dec;88(12):1846-9. doi: 10.2105/ajph.88.12.1846.
This study examined the prevalence and effects of potential barriers to removal of levonorgestrel implants (Norplant) among low-income women.
A sample of 687 women who received Norplant at hospital-based family planning clinics were interviewed before Norplant insertion and 6 months after Norplant insertion (or at Norplant removal if removal occurred earlier). Those who continued to use Norplant were reinterviewed at 2 years or at removal.
In a multivariate analysis, only 1 of the 4 potential barriers--cost--significantly impeded Norplant discontinuation.
Family planning clinics need to make clear that they follow a policy of Norplant removal on demand, regardless of the patient's ability to pay.
本研究调查了低收入女性中左炔诺孕酮植入剂（诺普兰）取出的潜在障碍的患病率及其影响。
选取687名在医院计划生育诊所接受诺普兰植入的女性作为样本，在植入前及植入后6个月（若提前取出则在取出时）进行访谈。继续使用诺普兰的女性在2年后或取出时再次接受访谈。
在多变量分析中，4个潜在障碍中只有一个——费用——显著阻碍了诺普兰的停用。
计划生育诊所需要明确表示，他们遵循按需取出诺普兰的政策，无论患者支付能力如何。
